Literature DB >> 28412069

Whole-Exome Sequencing Identifies Biallelic IDH3A Variants as a Cause of Retinitis Pigmentosa Accompanied by Pseudocoloboma.

Laurence H M Pierrache1, Adva Kimchi2, Rinki Ratnapriya3, Lisa Roberts4, Galuh D N Astuti5, Alexey Obolensky2, Avigail Beryozkin2, Martha J H Tjon-Fo-Sang6, Jose Schuil7, Caroline C W Klaver8, Ernie M H F Bongers9, Lonneke Haer-Wigman9, Nicoline Schalij10, Martijn H Breuning11, Gratia M Fischer12, Eyal Banin2, Raj S Ramesar4, Anand Swaroop3, L Ingeborgh van den Born13, Dror Sharon2, Frans P M Cremers14.   

Abstract

PURPOSE: To identify the genetic cause of and describe the phenotype in 4 families with autosomal recessive retinitis pigmentosa (arRP) that can be associated with pseudocoloboma.
DESIGN: Case series. PARTICIPANTS: Seven patients from 4 unrelated families with arRP, among whom 3 patients had bilateral early-onset macular pseudocoloboma.
METHODS: We performed homozygosity mapping and whole-exome sequencing in 5 probands and 2 unaffected family members from 4 unrelated families. Subsequently, Sanger sequencing and segregation analysis were performed in additional family members. We reviewed the medical history of individuals carrying IDH3A variants and performed additional ophthalmic examinations, including full-field electroretinography, fundus photography, fundus autofluorescence imaging, and optical coherence tomography. MAIN OUTCOME MEASURES: IDH3A variants, age at diagnosis, visual acuity, fundus appearance, visual field, and full-field electroretinography, fundus autofluorescence, and optical coherence tomography findings.
RESULTS: We identified 7 different variants in IDH3A in 4 unrelated families, that is, 5 missense, 1 nonsense, and 1 frameshift variant. All participants showed symptoms early in life, ranging from night blindness to decreased visual acuity, and were diagnosed between the ages of 1 and 11 years. Four participants with biallelic IDH3A variants displayed a typical arRP phenotype and 3 participants were diagnosed with arRP and pseudocoloboma of the macula.
CONCLUSIONS: IDH3A variants were identified as a novel cause of typical arRP in some individuals associated with macular pseudocoloboma. We observed both phenotypes in 2 siblings carrying the same compound heterozygous variants, which could be explained by variable disease expression and warrants caution when making assertions about genotype-phenotype correlations.
Copyright © 2017 American Academy of Ophthalmology. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28412069      PMCID: PMC5868413          DOI: 10.1016/j.ophtha.2017.03.010

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  34 in total

1.  Insights from retinitis pigmentosa into the roles of isocitrate dehydrogenases in the Krebs cycle.

Authors:  Dyonne T Hartong; Mayura Dange; Terri L McGee; Eliot L Berson; Thaddeus P Dryja; Roberta F Colman
Journal:  Nat Genet       Date:  2008-09-21       Impact factor: 38.330

2.  The prevalence of retinitis pigmentosa and congenital stationary night blindness in Israel.

Authors:  M Rosner; L Hefetz; F A Abraham
Journal:  Am J Ophthalmol       Date:  1993-09-15       Impact factor: 5.258

3.  North Carolina macular dystrophy phenotype in France maps to the MCDR1 locus.

Authors:  K W Small; B Puech; L Mullen; S Yelchits
Journal:  Mol Vis       Date:  1997-01-02       Impact factor: 2.367

4.  Thirty-Year follow-up of an African American family with macular dystrophy of the retina, locus 1 (North Carolina macular dystrophy).

Authors:  Daniel F Kiernan; Rohan J Shah; Seenu M Hariprasad; Michael A Grassi; Kent W Small; Joseph P Kiernan; William F Mieler
Journal:  Ophthalmology       Date:  2011-02-18       Impact factor: 12.079

5.  Mutations in the unfolded protein response regulator ATF6 cause the cone dysfunction disorder achromatopsia.

Authors:  Susanne Kohl; Ditta Zobor; Wei-Chieh Chiang; Nicole Weisschuh; Jennifer Staller; Irene Gonzalez Menendez; Stanley Chang; Susanne C Beck; Marina Garcia Garrido; Vithiyanjali Sothilingam; Mathias W Seeliger; Franco Stanzial; Francesco Benedicenti; Francesca Inzana; Elise Héon; Ajoy Vincent; Jill Beis; Tim M Strom; Günther Rudolph; Susanne Roosing; Anneke I den Hollander; Frans P M Cremers; Irma Lopez; Huanan Ren; Anthony T Moore; Andrew R Webster; Michel Michaelides; Robert K Koenekoop; Eberhart Zrenner; Randal J Kaufman; Stephen H Tsang; Bernd Wissinger; Jonathan H Lin
Journal:  Nat Genet       Date:  2015-06-01       Impact factor: 38.330

6.  Association between missense mutations in the BBS2 gene and nonsyndromic retinitis pigmentosa.

Authors:  Elia Shevach; Manir Ali; Liliana Mizrahi-Meissonnier; Martin McKibbin; Mohammed El-Asrag; Christopher M Watson; Chris F Inglehearn; Tamar Ben-Yosef; Anat Blumenfeld; Chaim Jalas; Eyal Banin; Dror Sharon
Journal:  JAMA Ophthalmol       Date:  2015-03       Impact factor: 7.389

7.  Exome sequencing identifies NMNAT1 mutations as a cause of Leber congenital amaurosis.

Authors:  Pei-Wen Chiang; Juan Wang; Yang Chen; Quan Fu; Jing Zhong; Yanhua Chen; Xin Yi; Renhua Wu; Haixue Gan; Yong Shi; Yanling Chen; Christopher Barnett; Dianna Wheaton; Megan Day; Joanne Sutherland; Elise Heon; Richard G Weleber; Luis Alexandre Rassi Gabriel; Peikuan Cong; KuangHsiang Chuang; Sheng Ye; Juliana Maria Ferraz Sallum; Ming Qi
Journal:  Nat Genet       Date:  2012-07-29       Impact factor: 38.330

8.  A missense mutation in the splicing factor gene DHX38 is associated with early-onset retinitis pigmentosa with macular coloboma.

Authors:  Muhammad Ajmal; Muhammad Imran Khan; Kornelia Neveling; Yar Muhammad Khan; Maleeha Azam; Nadia Khalida Waheed; Christian P Hamel; Tamar Ben-Yosef; Elfride De Baere; Robert K Koenekoop; Rob W J Collin; Raheel Qamar; Frans P M Cremers
Journal:  J Med Genet       Date:  2014-04-15       Impact factor: 6.318

9.  Exome sequencing extends the phenotypic spectrum for ABHD12 mutations: from syndromic to nonsyndromic retinal degeneration.

Authors:  Koji M Nishiguchi; Almudena Avila-Fernandez; Ramon A C van Huet; Marta Corton; Raquel Pérez-Carro; Esther Martín-Garrido; María Isabel López-Molina; Fiona Blanco-Kelly; Lies H Hoefsloot; Wendy A van Zelst-Stams; Pedro J García-Ruiz; Javier Del Val; Silvio Alessandro Di Gioia; B Jeroen Klevering; Bart P C van de Warrenburg; Carlos Vazquez; Frans P M Cremers; Blanca García-Sandoval; Carel B Hoyng; Rob W J Collin; Carlo Rivolta; Carmen Ayuso
Journal:  Ophthalmology       Date:  2014-03-31       Impact factor: 12.079

10.  Expanding the clinical, allelic, and locus heterogeneity of retinal dystrophies.

Authors:  Nisha Patel; Mohammed A Aldahmesh; Hisham Alkuraya; Shamsa Anazi; Hadeel Alsharif; Arif O Khan; Asma Sunker; Saleh Al-Mohsen; Emad B Abboud; Sawsan R Nowilaty; Mohammed Alowain; Hamad Al-Zaidan; Bandar Al-Saud; Ali Alasmari; Ghada M H Abdel-Salam; Mohamed Abouelhoda; Firdous M Abdulwahab; Niema Ibrahim; Ewa Naim; Banan Al-Younes; Abeer E AlMostafa; Abdulelah AlIssa; Mais Hashem; Olga Buzovetsky; Yong Xiong; Dorota Monies; Nada Altassan; Ranad Shaheen; Selwa A F Al-Hazzaa; Fowzan S Alkuraya
Journal:  Genet Med       Date:  2015-09-10       Impact factor: 8.822

View more
  12 in total

Review 1.  Cancer-associated mutation and beyond: The emerging biology of isocitrate dehydrogenases in human disease.

Authors:  Serena Tommasini-Ghelfi; Kevin Murnan; Fotini M Kouri; Akanksha S Mahajan; Jasmine L May; Alexander H Stegh
Journal:  Sci Adv       Date:  2019-05-22       Impact factor: 14.957

2.  Mouse Idh3a mutations cause retinal degeneration and reduced mitochondrial function.

Authors:  Amy S Findlay; Roderick N Carter; Becky Starbuck; Lisa McKie; Klára Nováková; Peter S Budd; Margaret A Keighren; Joseph A Marsh; Sally H Cross; Michelle M Simon; Paul K Potter; Nicholas M Morton; Ian J Jackson
Journal:  Dis Model Mech       Date:  2018-12-18       Impact factor: 5.758

3.  Molecular basis for the function of the αβ heterodimer of human NAD-dependent isocitrate dehydrogenase.

Authors:  Pengkai Sun; Tengfei Ma; Tianlong Zhang; Hanwen Zhu; Jianyang Zhang; Yabing Liu; Jianping Ding
Journal:  J Biol Chem       Date:  2019-09-12       Impact factor: 5.157

4.  The Potential Role of Epigenetic Mechanisms in the Development of Retinitis Pigmentosa and Related Photoreceptor Dystrophies.

Authors:  Galina Dvoriantchikova; Karin Rose Lypka; Dmitry Ivanov
Journal:  Front Genet       Date:  2022-03-11       Impact factor: 4.599

5.  miR-9-5p regulates immunometabolic and epigenetic pathways in β-glucan-trained immunity via IDH3α.

Authors:  Haibo Su; Zhongping Liang; ShuFeng Weng; Chaonan Sun; Jiaxin Huang; TianRan Zhang; Xialian Wang; Shanshan Wu; Zhi Zhang; Yiqi Zhang; Qing Gong; Ying Xu
Journal:  JCI Insight       Date:  2021-05-10

Review 6.  Toward an elucidation of the molecular genetics of inherited retinal degenerations.

Authors:  G Jane Farrar; Matthew Carrigan; Adrian Dockery; Sophia Millington-Ward; Arpad Palfi; Naomi Chadderton; Marian Humphries; Anna Sophia Kiang; Paul F Kenna; Pete Humphries
Journal:  Hum Mol Genet       Date:  2017-08-01       Impact factor: 6.150

7.  Alpha-1 Antitrypsin Attenuates M1 Microglia-Mediated Neuroinflammation in Retinal Degeneration.

Authors:  Tian Zhou; Zijing Huang; Xiaowei Zhu; Xiaowei Sun; Yan Liu; Bing Cheng; Mei Li; Yizhi Liu; Chang He; Xialin Liu
Journal:  Front Immunol       Date:  2018-05-30       Impact factor: 7.561

8.  De Novo Assembly-Based Analysis of RPGR Exon ORF15 in an Indigenous African Cohort Overcomes Limitations of a Standard Next-Generation Sequencing (NGS) Data Analysis Pipeline.

Authors:  Jordi Maggi; Lisa Roberts; Samuel Koller; George Rebello; Wolfgang Berger; Rajkumar Ramesar
Journal:  Genes (Basel)       Date:  2020-07-15       Impact factor: 4.096

9.  Longitudinal Changes of Macular Curvature in Patients with Retinitis Pigmentosa.

Authors:  Monika Meinert; Shinji Ueno; Shiori Komori; Yoshito Koyanagi; Akira Sayo; Sten Andreasson; Taro Kominami; Yasuki Ito; Hiroko Terasaki
Journal:  Transl Vis Sci Technol       Date:  2020-09-10       Impact factor: 3.283

Review 10.  Photoreceptor metabolic reprogramming: current understanding and therapeutic implications.

Authors:  Warren W Pan; Thomas J Wubben; Cagri G Besirli
Journal:  Commun Biol       Date:  2021-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.